Embed Multiple Sclerosis - New Drug - Infographic on your site
A newly-tested treatment for multiple sclerosis reduces relapse and deterioration in patients, without many of the negative side effects associated with other treatments, says a study.
A clinical study published Wednesday in the New England Journal of Medicine (NEJM) said that Cladribine was the first oral medication for patients suffering from MS, a complex neurological condition.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer